Plimoth Trust Co. LLC Sells 9,646 Shares of CVS Health Co. (NYSE:CVS)

Plimoth Trust Co. LLC trimmed its stake in CVS Health Co. (NYSE:CVS - Free Report) by 24.4% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 29,961 shares of the pharmacy operator's stock after selling 9,646 shares during the quarter. Plimoth Trust Co. LLC's holdings in CVS Health were worth $1,345,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in CVS. MidAtlantic Capital Management Inc. purchased a new stake in shares of CVS Health during the 3rd quarter valued at approximately $25,000. Ridgewood Investments LLC increased its holdings in CVS Health by 255.7% during the 4th quarter. Ridgewood Investments LLC now owns 626 shares of the pharmacy operator's stock worth $28,000 after acquiring an additional 450 shares during the period. Livelsberger Financial Advisory bought a new stake in CVS Health during the 3rd quarter worth approximately $31,000. Legacy Investment Solutions LLC bought a new stake in CVS Health during the 3rd quarter worth approximately $31,000. Finally, Reston Wealth Management LLC bought a new stake in CVS Health during the 3rd quarter worth approximately $32,000. 80.66% of the stock is currently owned by hedge funds and other institutional investors.

CVS Health Trading Down 0.6 %

CVS traded down $0.33 during trading on Wednesday, hitting $57.00. 11,611,804 shares of the stock traded hands, compared to its average volume of 13,652,173. The firm has a market capitalization of $71.73 billion, a P/E ratio of 14.47, a price-to-earnings-growth ratio of 0.80 and a beta of 0.59. The company has a debt-to-equity ratio of 0.80, a current ratio of 0.80 and a quick ratio of 0.59. The firm has a 50-day moving average of $51.27 and a 200 day moving average of $56.18. CVS Health Co. has a 12-month low of $43.56 and a 12-month high of $80.75.

CVS Health (NYSE:CVS - Get Free Report) last posted its earnings results on Wednesday, November 6th. The pharmacy operator reported $1.09 EPS for the quarter, topping the consensus estimate of $1.08 by $0.01. CVS Health had a net margin of 1.36% and a return on equity of 10.72%. The firm had revenue of $95.43 billion during the quarter, compared to analysts' expectations of $92.72 billion. During the same period last year, the company posted $2.21 EPS. The company's quarterly revenue was up 6.3% compared to the same quarter last year. Equities research analysts anticipate that CVS Health Co. will post 5.22 EPS for the current year.

CVS Health Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Monday, February 3rd. Stockholders of record on Thursday, January 23rd will be given a $0.665 dividend. The ex-dividend date is Thursday, January 23rd. This represents a $2.66 annualized dividend and a dividend yield of 4.67%. CVS Health's dividend payout ratio is 67.51%.

Analyst Ratings Changes

A number of analysts recently weighed in on the stock. Piper Sandler decreased their target price on shares of CVS Health from $72.00 to $64.00 and set an "overweight" rating on the stock in a report on Monday, November 25th. Wells Fargo & Company raised shares of CVS Health from an "equal weight" rating to an "overweight" rating and upped their target price for the stock from $60.00 to $66.00 in a report on Monday, November 18th. Mizuho decreased their target price on shares of CVS Health from $73.00 to $66.00 and set an "outperform" rating on the stock in a report on Thursday, October 24th. Cantor Fitzgerald reissued a "neutral" rating and issued a $62.00 price target on shares of CVS Health in a report on Tuesday, October 1st. Finally, Royal Bank of Canada decreased their price target on shares of CVS Health from $68.00 to $58.00 and set an "outperform" rating on the stock in a report on Friday, November 15th. One research analyst has rated the stock with a sell rating, six have issued a hold rating and thirteen have given a buy rating to the company. According to MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and a consensus target price of $68.12.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.